vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and TH International Ltd (THCH). Click either name above to swap in a different company.

TH International Ltd is the larger business by last-quarter revenue ($6.6M vs $3.5M, roughly 1.9× COMPUGEN LTD). TH International Ltd runs the higher net margin — -41.2% vs -410.1%, a 369.0% gap on every dollar of revenue.

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

TH International Ltd is the exclusive operator of the Tim Hortons coffee brand in mainland China. It offers freshly brewed coffee, artisanal baked goods, light meals and branded peripheral products, operating physical offline stores and third-party delivery channels, targeting young urban consumers across tier 1, tier 2 and tier 3 cities in China.

CGEN vs THCH — Head-to-Head

Bigger by revenue
THCH
THCH
1.9× larger
THCH
$6.6M
$3.5M
CGEN
Higher net margin
THCH
THCH
369.0% more per $
THCH
-41.2%
-410.1%
CGEN

Income Statement — Q2 FY2025 vs Q1 FY2024

Metric
CGEN
CGEN
THCH
THCH
Revenue
$3.5M
$6.6M
Net Profit
$-14.5M
$-2.7M
Gross Margin
Operating Margin
-475.1%
-37.3%
Net Margin
-410.1%
-41.2%
Revenue YoY
-61.8%
Net Profit YoY
-54.7%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
THCH
THCH
Q2 25
$3.5M
Q2 24
$9.3M
Q1 24
$2.6M
$6.6M
Q2 23
$0
Net Profit
CGEN
CGEN
THCH
THCH
Q2 25
$-14.5M
Q2 24
$-9.4M
Q1 24
$7.3M
$-2.7M
Q2 23
$-18.6M
Gross Margin
CGEN
CGEN
THCH
THCH
Q2 25
Q2 24
60.5%
Q1 24
17.9%
Q2 23
Operating Margin
CGEN
CGEN
THCH
THCH
Q2 25
-475.1%
Q2 24
-128.5%
Q1 24
-37.3%
Q2 23
Net Margin
CGEN
CGEN
THCH
THCH
Q2 25
-410.1%
Q2 24
-101.4%
Q1 24
284.0%
-41.2%
Q2 23
EPS (diluted)
CGEN
CGEN
THCH
THCH
Q2 25
$-0.16
Q2 24
$-0.10
Q1 24
$89505618.00
Q2 23
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
THCH
THCH
Cash + ST InvestmentsLiquidity on hand
$35.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.3M
Total Assets
$106.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
THCH
THCH
Q2 25
$35.3M
Q2 24
$44.6M
Q1 24
$39.3M
Q2 23
$21.6M
Stockholders' Equity
CGEN
CGEN
THCH
THCH
Q2 25
$50.3M
Q2 24
$58.3M
Q1 24
$65.6M
Q2 23
$62.0M
Total Assets
CGEN
CGEN
THCH
THCH
Q2 25
$106.5M
Q2 24
$110.2M
Q1 24
$121.3M
Q2 23
$77.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
THCH
THCH
Operating Cash FlowLast quarter
$-18.6M
$-511
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
THCH
THCH
Q2 25
$-18.6M
Q2 24
$39.7M
Q1 24
$-511
Q2 23
$-18.6M
Free Cash Flow
CGEN
CGEN
THCH
THCH
Q2 25
$-18.8M
Q2 24
$39.7M
Q1 24
Q2 23
$-18.6M
FCF Margin
CGEN
CGEN
THCH
THCH
Q2 25
-530.8%
Q2 24
428.3%
Q1 24
Q2 23
Capex Intensity
CGEN
CGEN
THCH
THCH
Q2 25
6.5%
Q2 24
0.4%
Q1 24
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons